Page last updated: 2024-09-02

quinone methide and ER-Negative PR-Negative HER2-Negative Breast Cancer

quinone methide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaouen, G; McGlinchey, MJ; Pigeon, P; Top, S; Wang, Y1

Other Studies

1 other study(ies) available for quinone methide and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.
    Angewandte Chemie (International ed. in English), 2015, Aug-24, Volume: 54, Issue:35

    Topics: Cell Proliferation; Chromatography, High Pressure Liquid; Cyclization; Ferrous Compounds; Hep G2 Cells; Humans; Indolequinones; Organometallic Compounds; Oxidation-Reduction; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2015